Goldman Sachs’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-184
| Closed | -$3.18K | – | 5086 |
|
|
2024
Q4 | $3.18K | Buy |
+184
| New | +$3.18K | ﹤0.01% | 4976 |
|
|
2023
Q3 | – | Sell |
-731
| Closed | -$268K | – | 4742 |
|
|
2023
Q2 | $268K | Sell |
731
-42
| -5% | -$15.4K | ﹤0.01% | 4282 |
|
|
2023
Q1 | $515K | Sell |
773
-711
| -48% | -$474K | ﹤0.01% | 4059 |
|
|
2022
Q4 | $1.3M | Sell |
1,484
-25
| -2% | -$21.9K | ﹤0.01% | 3547 |
|
|
2022
Q3 | $1.66M | Buy |
1,509
+259
| +21% | +$284K | ﹤0.01% | 3485 |
|
|
2022
Q2 | $1.04M | Buy |
1,250
+213
| +21% | +$176K | ﹤0.01% | 3917 |
|
|
2022
Q1 | $1.61M | Sell |
1,037
-10
| -1% | -$15.5K | ﹤0.01% | 3739 |
|
|
2021
Q4 | $1.88M | Buy |
1,047
+581
| +125% | +$1.04M | ﹤0.01% | 3546 |
|
|
2021
Q3 | $1.54M | Sell |
466
-292
| -39% | -$964K | ﹤0.01% | 3677 |
|
|
2021
Q2 | $3.33M | Buy |
758
+424
| +127% | +$1.86M | ﹤0.01% | 3090 |
|
|
2021
Q1 | $1.62M | Buy |
+334
| New | +$1.62M | ﹤0.01% | 3551 |
|